Your browser doesn't support javascript.
loading
Lymphangiogenesis is a feature of acute GVHD, and VEGFR-3 inhibition protects against experimental GVHD.
Mertlitz, Sarah; Shi, Yu; Kalupa, Martina; Grötzinger, Carsten; Mengwasser, Jörg; Riesner, Katarina; Cordes, Steffen; Elezkurtaj, Sefer; Penack, Olaf.
Afiliação
  • Mertlitz S; Department of Hematology, Oncology, and Tumor Immunology, and.
  • Shi Y; Department of Hematology, Oncology, and Tumor Immunology, and.
  • Kalupa M; Department of Hematology, Oncology, and Tumor Immunology, and.
  • Grötzinger C; Department of Hepatology and Gastroenterology and Molecular Cancer Research Center, Tumor Targeting Laboratory, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany; and.
  • Mengwasser J; Department of Hematology, Oncology, and Tumor Immunology, and.
  • Riesner K; Department of Hematology, Oncology, and Tumor Immunology, and.
  • Cordes S; Department of Hematology, Oncology, and Tumor Immunology, and.
  • Elezkurtaj S; Institute for Pathology, Charité University Medicine, Campus Mitte, Berlin, Germany.
  • Penack O; Department of Hematology, Oncology, and Tumor Immunology, and.
Blood ; 129(13): 1865-1875, 2017 03 30.
Article em En | MEDLINE | ID: mdl-28096093

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptor 3 de Fatores de Crescimento do Endotélio Vascular / Linfangiogênese / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptor 3 de Fatores de Crescimento do Endotélio Vascular / Linfangiogênese / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article